The DOI matches its Crossref record; 298 of the 298 references it cites were found in a registry or an index.
Exploiting replicative stress to treat cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–298 of 298
Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1
Kumagai, A., & Dunphy, W. G. (2003) · Nature Cell Biology · doi:10.1038/ncb921 · Cited by 171
Guzi, T. J., Paruch, K., Dwyer, M. P., Labroli, M., Shanahan, F., Davis, N., Taricani, L., Wiswell, D., Seghezzi, W., Penaflor, E., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0928 · Cited by 171
Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress
Arlander, S. J. H., Eapen, A. K., Vroman, B. T., McDonald, R. J., Toft, D. O., & Karnitz, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309054200 · Cited by 169
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
Beck, H., Nähse, V., Larsen, M. S. Y., Groth, P., Clancy, T., Lees, M., Jørgensen, M., Helleday, T., Syljuåsen, R. G., & Sørensen, C. S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905059 · Cited by 169
Self-citationXRCC3 and Rad51 Modulate Replication Fork Progression on Damaged Vertebrate Chromosomes
Henry-Mowatt, J., Jackson, D., Masson, J.-Y., Johnson, P. A., Clements, P. M., Benson, F. E., Thompson, L. H., Takeda, S., West, S. C., & Caldecott, K. W. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00132-1 · Cited by 164
Milhollen, M. A., Narayanan, U., Soucy, T. A., Veiby, P. O., Smith, P. G., & Amidon, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2122 · Cited by 159
Conti, C., Leo, E., Eichler, G. S., Sordet, O., Martin, M. M., Fan, A. M., Aladjem, M. I., & Pommier, Y. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3028 · Cited by 159
Controlling DNA replication origins in response to DNA damage – inhibit globally, activate locally
Yekezare, M., Gómez‐González, B., & Diffley, J. F. X. (2013) · Journal of Cell Science · doi:10.1242/jcs.096701 · Cited by 158
Chung, S., Suzuki, H., Miyamoto, T., Takamatsu, N., Tatsuguchi, A., Ueda, K., Kijima, K., Nakamura, Y., & Matsuo, Y. (2012) · Oncotarget · doi:10.18632/oncotarget.790 · Cited by 158
Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA
Sung, J., & Demple, B. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05192.x · Cited by 157
Nickeleit, I., Zender, S., Sasse, F., Geffers, R., Brandes, G., Sörensen, I., Steinmetz, H., Kubicka, S., Carlomagno, T., Menche, D., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.016 · Cited by 154
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins
Felsani, A., Mileo, A. M., & Paggi, M. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209621 · Cited by 150
Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21
Cayrol, C., & Ducommun, B. (1998) · Oncogene · doi:10.1038/sj.onc.1202189 · Cited by 147
Prospective therapeutic applications of p53 inhibitors
Gudkov, A. V., & Komarova, E. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.153 · Cited by 142
Robison, J. G., Elliott, J., Dixon, K., & Oakley, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404750200 · Cited by 141
Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells
Montagnoli, A., Tenca, P., Sola, F., Carpani, D., Brotherton, D. H., Albanese, C., & Santocanale, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1547 · Cited by 141
Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
Höglund, A., Nilsson, L. M., Muralidharan, S. V., Hasvold, L. A., Merta, P. J., Rudelius, M., Nikolova, V. D., Keller, U. B., & Nilsson, J. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1198 · Cited by 140
Single- and double-stranded DNA: building a trigger of ATR-mediated DNA damage response: Figure 1.Preprint
Zou, L. (2007) · Genes & Development · doi:10.1101/gad.1550307 · Cited by 134
Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
Russell, M. R., Levin, K., Rader, J., Belcastro, L. T., Li, Y., Martínez, D., Pawel, B., Shumway, S. D., Maris, J. M., & Cole, K. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2669 · Cited by 130
SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation
Jørgensen, S., Eskildsen, M., Fugger, K., Hansen, L., Larsen, M. S. Y., Kousholt, A. N., Syljuåsen, R. G., Trelle, M. B., Jensen, O. N., Helin, K., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201009076 · Cited by 130
Self-citationMin, W., Bruhn, C., Grigaravičius, P., Zhou, Z., Li, F., Krüger, A., Siddeek, B., Greulich, K., Popp, O., Meisezahl, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3993 · Cited by 129
BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage
Pathania, S., Nguyen, J., Hill, S. J., Scully, R., Adelmant, G., Marto, J. A., Feunteun, J., & Livingston, D. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.002 · Cited by 127
Marine Natural Product Aurilide Activates the OPA1-Mediated Apoptosis by Binding to Prohibitin
Sato, S., Murata, A., Orihara, T., Shirakawa, T., Suenaga, K., Kigoshi, H., & Uesugi, M. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.10.017 · Cited by 127
An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation
Lopez-Contreras, A. J., Gutierrez‐Martinez, P., Specks, J., Rodrigo-Perez, S., & Fernández-Capetillo, Ó. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112147 · Cited by 123
Karp, J. E., Thomas, B. M., Greer, J. M., Sorge, C. L., Gore, S. D., Pratz, K. W., Smith, B. D., Flatten, K. S., Peterson, K., Schneider, P. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2442 · Cited by 123
Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy
Montagnoli, A., Moll, J. K., & Colotta, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0185 · Cited by 122
RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cellsPreprint
Ragland, R. L., Patel, S., Rivard, R. S., Smith, K. D., Peters, A. A., Bielinsky, A., & Brown, E. J. (2013) · Genes & Development · doi:10.1101/gad.223180.113 · Cited by 120
A Proteomic Characterization of Factors Enriched at Nascent DNA Molecules
Lopez-Contreras, A. J., Ruppen, I., Nieto-Soler, M., Murga, M., Rodríguez‐Acebes, S., Remeseiro, S., Rodrigo-Perez, S., Rojas, A. M., Méndez, J., Muñoz, J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.009 · Cited by 118
Beyer, U., Moll-Rocek, J., Moll, U. M., & Dobbelstein, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016201108 · Cited by 117
Self-citationTargeting homologous recombination repair defects in cancer
Evers, B., Helleday, T., & Jonkers, J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.001 · Cited by 117
Raman, M., Havens, C. G., Walter, J. C., & Harper, J. W. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.036 · Cited by 115
Ma, C. X., Ellis, M. J., Petroni, G. R., Guo, Z., Cai, S.-R., Ryan, C. E., Lockhart, A. C., Naughton, M. J., Pluard, T., Brenin, C. M., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2378-9 · Cited by 114
Anderson, V. E., Walton, M. I., Eve, P. D., Boxall, K. J., Antoni, L., Caldwell, J., Aherne, W., Pearl, L. H., Oliver, A. W., Collins, I., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1252 · Cited by 114
Carrassa, L., Chilà, R., Lupi, M., Ricci, F., Celenza, C., Mazzoletti, M., Broggini, M., & Damia, G. L. M. (2012) · Cell Cycle · doi:10.4161/cc.20899 · Cited by 113
Milhollen, M. A., Thomas, M. P., Narayanan, U., Traore, T., Riceberg, J., Amidon, B., Bence, N., Bolen, J. B., Brownell, J. E., Dick, L. R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.009 · Cited by 109
Atm-dependent interactions of a mammalian Chk1 homolog with meiotic chromosomes
Flaggs, G., Plug, A. W., Dunks, K. M., Mundt, K., Ford, J. C., Quiggle, M. R. E., Taylor, E. M., Westphal, C. H., Ashley, T., Hoekstra, M. F., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00417-9 · Cited by 108
Azorsa, D. O., Gonzales, I. M., Basu, G. D., Choudhary, A. K., Arora, S., Bisanz, K. M., Kiefer, J., Henderson, M. C., Trent, J. M., Hoff, D. D. V., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-43 · Cited by 108
Seto, T., Esaki, T., Hirai, F., Arita, S., Nosaki, K., Makiyama, A., Kometani, T., Fujimoto, C., Hamatake, M., Takeoka, H., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2234-6 · Cited by 104
Morandell, S., Reinhardt, H. C., Cannell, I. G., Kim, J. S., Ruf, D. M., Mitra, T., Couvillon, A. D., Jacks, T., & Yaffe, M. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.025 · Cited by 99
Hsp90 phosphorylation, Wee1 and the cell cycle
Mollapour, M., Tsutsumi, S., & Neckers, L. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12054 · Cited by 95
FANCD2 Binds CtIP and Regulates DNA-End Resection during DNA Interstrand Crosslink Repair
Unno, J., Itaya, A., Taoka, M., Sato, K., Tomida, J., Sakai, W., Sugasawa, K., Ishiai, M., Ikura, T., Isobe, T., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.005 · Cited by 94
Fernet, M., Mégnin-Chanet, F., Hall, J. A., & Favaudon, V. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.10.006 · Cited by 94
Giroux, V., Iovanna, J., & Dagorn, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6239com · Cited by 90
Costa, D. D., Agathanggelou, A., Perry, T., Weston, V., Petermann, E., Zlatanou, A., Oldreive, C., Wei, W., Stewart, G. S., Longman, J., et al. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.24 · Cited by 88
Yamada, M., Watanabe, K., Mistrík, M., Veselá, E., Protivankova, I., Mailand, N., Lee, M., Masai, H., Lukas, J., & Bartek, J. (2013) · Genes & Development · doi:10.1101/gad.224568.113 · Cited by 87
Heterozygous mutations in PALB2 cause DNA replication and damage response defects
Nikkilä, J., Parplys, A. C., Pylkäs, K., Bose, M., Huo, Y., Borgmann, K., Rapakko, K., Nieminen, P. A., Xia, B., Pospiech, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3578 · Cited by 85
Nongenotoxic p53 Activation Protects Cells against S-Phase–Specific Chemotherapy
Kranz, D., & Dobbelstein, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1527 · Cited by 85
Self-citationA Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
Toth, J. I., Yang, L., Dahl, R. S., & Petroski, M. D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.006 · Cited by 84
Piwko, W., Olma, M. H., Held, M., Bianco, J. N., Pedrioli, P. G. A., Hofmann, K., Pasero, P., Gerlich, D. W., & Peter, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.304 · Cited by 84
Hebbard, L., Maurer, J., Miller, A., Lesperance, J., Hassell, J. A., Oshima, R. G., & Terskikh, A. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1295 · Cited by 82
Ha, K., Fiskus, W. C., Rao, R., Balusu, R., Venkannagari, S., Nalabothula, N. R., & Bhalla, K. N. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0094 · Cited by 82
Shiotani, B., & Zou, L. (2009) · Journal of Cell Science · doi:10.1242/jcs.035105 · Cited by 82
Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
Davies, K. D., Cable, P. L., Garrus, J. E., Sullivan, F. X., von Carlowitz, I., Huérou, Y. L., Wallace, E. M., Woessner, R. D., & Gross, S. D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17673 · Cited by 81
Groth, P., Orta, M. L., Elvers, I., Majumder, M. M., Lagerqvist, A., & Helleday, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks315 · Cited by 81
Guertin, A. D., Martin, M. M., Roberts, B. S., Hurd, M. S., Qu, X., Miselis, N. R., Liu, Y., Li, J., Feldman, I., Benita, Y., et al. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-45 · Cited by 81
Phosphorylation of Mcm2 by Cdc7 Promotes Pre-replication Complex Assembly during Cell-Cycle Re-entry
Chuang, L.-C., Teixeira, L. K., Wohlschlegel, J. A., Henze, M., Yates, J. R., Méndez, J., & Reed, S. I. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.014 · Cited by 80
Chaudhuri, L., Vincelette, N. D., Koh, B. D., Naylor, R. M., Flatten, K. S., Peterson, K. L., McNally, A., Gojo, I., Karp, J. E., Mesa, R. A., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.093187 · Cited by 80
Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity
Köpper, F., Bierwirth, C., Schön, M., Kunze, M., Elvers, I., Kranz, D., Saini, P., Menon, M., Walter, D., Sørensen, C. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304355110 · Cited by 79
Self-citationOrta, M. L., Calderón‐Montaño, J. M., Domínguez, I., Pastor, N., Burgos‐Morón, E., López‐Lázaro, M., Cortés, F., Mateos, S., & Helleday, T. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt270 · Cited by 74
Perez, R. P., Lewis, L. D., Beelen, A. P., Olszanski, A. J., Johnston, N., Rhodes, C. H., Beaulieu, B. B., Ernstoff, M. S., & Eastman, A. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0197 · Cited by 73
McNees, C. J., Tejera, Á. M., Martínez, P., Murga, M., Mulero, F., Fernández-Capetillo, Ó., & Blasco, M. A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200908136 · Cited by 71
An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination
Zeng, X., & King, R. W. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.801 · Cited by 70
The Chromatin Scaffold Protein SAFB1 Renders Chromatin Permissive for DNA Damage Signaling
Altmeyer, M., Toledo, L. I., Guðjόnsson, Þ., Grøfte, M., Rask, M., Lukas, C., Akimov, V., Blagoev, B., Bártek, J., & Lukas, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.025 · Cited by 69
Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents
Kee, Y., Huang, M., Chang, S. C., Moreau, L. A., Park, E., Smith, P. G., & D’Andrea, A. D. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0497 · Cited by 68
Sato, K., Ishiai, M., Toda, K., Furukoshi, S., Osakabe, A., Tachiwana, H., Takizawa, Y., Kagawa, W., Kitao, H., Dohmae, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.197 · Cited by 68
Regulation of p73 activity by post-translational modifications
Conforti, F., Sayan, E., Sreekumar, R., & Sayan, B. S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.27 · Cited by 67
Defining replication origin efficiency using DNA fiber assays
Tuduri, S., Tourrière, H., & Pasero, P. (2009) · Chromosome Research · doi:10.1007/s10577-009-9098-y · Cited by 67
Rao, B., Laín, S., & Thompson, A. M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.702 · Cited by 67
A rapid and efficient method to purify proteins at replication forks under native conditions
Leung, K. H. T., Hassan, M. A. E., & Bremner, R. (2013) · BioTechniques · doi:10.2144/000114089 · Cited by 66
Tort, F., Bártková, J., Sehested, M., Orntoft, T. F., Lukas, J., & Bártek, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2178 · Cited by 66
ATR mediates cisplatin resistance in a p53 genotype-specific manner
Sangster‐Guity, N., Conrad, B., Papadopoulos, N., & Bunz, F. (2011) · Oncogene · doi:10.1038/onc.2010.624 · Cited by 65
Translesion DNA synthesis in the context of cancer research
Knobel, P. A., & Marti, T. M. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-39 · Cited by 64
Targeting DNA Replication before it Starts
Rodríguez‐Acebes, S., Proctor, I., Loddo, M., Wollenschlaeger, A., Rashid, M., Falzon, M., Prevost, A. T., Sainsbury, R., Stoeber, K., & Williams, G. H. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100421 · Cited by 58
Fahy, B. N., Schlieman, M. G., Virudachalam, S., & Bold, R. J. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00201-4 · Cited by 58
Li, T., Christensen, S., Frankel, P. H., Margolin, K. A., Agarwala, S. S., Luu, T. H., Mack, P. C., Lara, P. N., & Gandara, D. R. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9562-8 · Cited by 58
Matranga, C. B., & Shapiro, G. I. (2002) · PubMed · Cited by 55
Fhit and CHK1 Have Opposing Effects on Homologous Recombination Repair
Hu, B., Wang, H., Wang, X., Lu, H., Huang, C.-F., Powell, S. N., Huebner, K., & Wang, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1966 · Cited by 52
Garcia, K., Blank, J. L., Bouck, D. C., Liu, X. J., Sappal, D. S., Hather, G., Cosmopoulos, K., Thomas, M. P., Kuranda, M., Pickard, M. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0634 · Cited by 52
The Radioresistance to Killing of A1–5 Cells Derives from Activation of the Chk1 Pathway
Hu, B., Zhou, X.-Y., Wang, X., Zeng, Z., Iliakis, G. E., & Wang, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009340200 · Cited by 49
Fehm, T. N., Banys, Hartkopf, Krawczyk, Meier-Stiegen, Neubauer, H. J., & Kaiser (2012) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s26431 · Cited by 48
A switch between DNA polymerases δ and λ promotes error-free bypass of 8-oxo-G lesions
Markkanen, E., Castrec, B., Villani, G., & Hübscher, U. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211532109 · Cited by 48
Diminished Origin-Licensing Capacity Specifically Sensitizes Tumor Cells to Replication Stress
Savill, K. M. Z., Jones, R. M., Petermann, E., & Jeggo, P. A. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0491 · Cited by 47
Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death
Loegering, D. A., Arlander, S. J. H., Hackbarth, J. S., Vroman, B. T., Roos‐Mattjus, P., Hopkins, K. M., Lieberman, H. B., Karnitz, L. M., & Kaufmann, S. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313536200 · Cited by 44
Regulation and roles of Cdc7 kinase under replication stress
Yamada, M., Masai, H., & Bártek, J. (2014) · Cell Cycle · doi:10.4161/cc.29251 · Cited by 42
Rescue of replication failure by Fanconi anaemia proteins
Constantinou, A. (2011) · Chromosoma · doi:10.1007/s00412-011-0349-2 · Cited by 40
Hoffmann, J., & Cazaux, C. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.001 · Cited by 40
BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways
Kranz, D., Dohmesen, C., & Dobbelstein, M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712014 · Cited by 39
Self-citationHelleday, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu158 · Cited by 37
Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine
Fredebohm, J., Wolf, J. M., Hoheisel, J. D., & Boettcher, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.124768 · Cited by 33
Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.
Yazlovitskaya, E. M., & Persons, D. L. (2003) · PubMed · Cited by 29
Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice
Helleday, T. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000016 · Cited by 27
Cho, Y., Kang, Y. J., Kim, K., Cha, Y., & Cho, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.034 · Cited by 26
p53-induced p21 controls DNA replication.
Waga, S., Li, R., & Stillman, B. (1997) · PubMed · Cited by 24
Damrot, J., Helbig, L., Roos, W. P., Quirós, S., Kaina, B., & Fritz, G. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.015 · Cited by 20
Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells
Ali, S. S., El-Rayes, B. F., Aranha, O., Sarkar, F. H., & Philip, P. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2179-x · Cited by 20
Tanaka, T., Nakatani, T., & Kamitani, T. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319220017 · Cited by 20
Portrait of replication stress viewed from telomeres
Ishikawa, F. (2013) · Cancer Science · doi:10.1111/cas.12165 · Cited by 18
Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells
Blagosklonny, M. V. (2012) · Oncotarget · doi:10.18632/oncotarget.548 · Cited by 14
Cited by
PARP and PARG inhibitors in cancer treatment
Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 667
Unravelling the biology of SCLC: implications for therapy
Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T., & Rudin, C. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.71 · Cited by 490
Targeting replication stress in cancer therapy
da Costa, A. A. B. A., Chowdhury, D., Shapiro, G. I., D’Andrea, A. D., & Konstantinopoulos, P. A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00558-5 · Cited by 359
Increased global transcription activity as a mechanism of replication stress in cancer
Kotsantis, P., Silva, L. M., Irmscher, S., Jones, R. M., Folkes, L., Gromak, N., & Petermann, E. (2016) · Nature Communications · doi:10.1038/ncomms13087 · Cited by 336
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Damia, G., & Broggini, M. (2019) · Cancers · doi:10.3390/cancers11010119 · Cited by 298
Metadata
- Authors
- Dobbelstein, M., & Sørensen, C. S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-05-08
- Volume
- 14
- Issue
- 6
- Pages
- 405-423
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1628408467
- Cited by
- 302
- References
- 298
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.